Market Tracker

07/27 4:45pm ET

Novo Nordisk A/S (NYSE:NVO)

56.34
Delayed Data
As of Jul 27
 +0.05 / +0.09%
Today’s Change
46.17
Today|||52-Week Range
60.34
-3.00%
Year-to-Date
3 Stocks Pushing The Drugs Industry Downward
Jul 27 / TheStreet.com - Paid Partner Content
Novo Nordisk A/S (NVO) Trading With Heavy Volume Before Market Open
Jul 26 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close56.29
Today’s open55.85
Day’s range55.83 - 56.41
Volume1,460,974
Average volume (3 months)1,264,572
Market cap$110.4B
Dividend yield1.70%
Data as of 4:02pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.29%
Revenue growth (last year)+1.43%
P/E ratio4.2
Price/Sales9.38
Price/Book20.98

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.32+0.76%
GSKGlaxoSmithKline+0.96+2.17%
ABBVAbbVie+0.45+0.70%
AGNAllergan+11.29+4.54%
Data as of 4:02pm ET, 07/27/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)$0.58
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts